Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M507Revenue $M126Net Margin (%)10.1Z-Score23.8
Enterprise Value $M470EPS $0.7Operating Margin %15.8F-Score5
P/E(ttm))40.7Cash Flow Per Share $0.6Pre-tax Margin (%)15.8Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %0Quick Ratio4.8Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %16.4Current Ratio6.0Lower Leverage y-yY
Price/Cash Flow21.9y-y EBITDA Growth Rate %16.7ROA % (ttm)10.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)12.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M17.2ROI % (ttm)13.8Gross Margin Increase y-yN

Gurus Latest Trades with VASC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
VASCJoel Greenblatt 2014-12-31 Buy $23.74 - $30.54
$ 29.468%New holding8,442
VASCJoel Greenblatt 2014-09-30 Sold Out -0.01%$21.87 - $25.07
$ 29.4619%Sold Out0
VASCJoel Greenblatt 2014-03-31 Buy 0.01%$22.99 - $26.92
$ 29.4616%New holding24,570
VASCJoel Greenblatt 2013-03-31 Sold Out -0.01%$14.4 - $16.71
$ 29.4647%Sold Out0
VASCJoel Greenblatt 2012-12-31 Buy 0.01%$13.32 - $15.35
$ 29.4650%New holding10,137
VASCMario Gabelli 2011-03-31 Reduce-0.01%$10.48 - $12.06
$ 29.4663%Reduce -32.85%397,196
VASCMario Gabelli 2010-09-30 Add0.01%$10.93 - $12.64
$ 29.4660%Add 41.04%600,796
VASCMario Gabelli 2010-06-30 Reduce-0.01%$9.05 - $13.04
$ 29.4664%Reduce -32.34%425,971
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VASC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

VASC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
O'CONNELL PAULDirector 2015-02-25Sell2,583$28.715.22view
ERB JOHN LDirector 2015-02-18Sell10,000$28.565.78view
RUTSTEIN WILLIAMSr. VP of International Sales 2015-02-10Sell10,814$26.9112.26view
POWERS CARRIEVP of Marketing 2015-02-10Sell15,794$26.8112.68view
ROOT HOWARDCEO 2015-02-09Sell25,000$28.575.74view
HENNEN JAMESSr. VP of Finance and CFO 2015-02-05Sell11,301$27.629.38view
SAUCEDO JORGEDirector 2015-02-05Sell10,000$27.3610.42view
NIGON RICHARDDirector 2014-11-26Buy3,000$25.817.09view
KRAMP RICHARD WDirector 2014-11-14Buy1,475$23.6927.52view
Slayton TimothyPrincipal Accounting Officer 2014-04-24Sell1,390$23.1530.5view

Press Releases about VASC :

    Quarterly/Annual Reports about VASC:

    News about VASC:

    Articles On GuruFocus.com
    Vascular Solutions Inc. Reports Operating Results (10-K) Feb 01 2011 
    Vascular Solutions Inc. (VASC) CEO Howard Root sells 25,000 Shares Nov 04 2010 
    Vascular Solutions Inc. Reports Operating Results (10-K) Feb 02 2010 
    Vascular Solutions Inc. Reports Operating Results (10-Q) Apr 17 2009 
    Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call Tuesday, February 3, 2009 at 3:30 Jan 08 2009 

    More From Other Websites
    Vascular Solutions Announces Q1 Earnings Date Mar 31 2015
    Vascular Solutions, Inc. to Webcast First Quarter Conference Call Mar 31 2015
    Vascular Solutions Launches PolarCath™ Peripheral Dilatation System Mar 16 2015
    Vascular Solutions Launches PolarCath(TM) Peripheral Dilatation System Mar 16 2015
    The Zacks Analyst Blog Highlights: Medtronic, Abaxis, Vascular Solutions and Cardiovascular Systems... Mar 06 2015
    Medtronic Positive on Covidien Integration, Potential Synergy - Analyst Blog Mar 05 2015
    Bioscrip Q4 Loss Wider than Expected, Revenues Up Y/Y - Analyst Blog Mar 04 2015
    Walgreens Boots: Market Optimism on Merger Makes It a Buy - Analyst Blog Feb 26 2015
    Medtronic's VenaSeal Wins FDA Nod for Vericose Veins Cure - Analyst Blog Feb 26 2015
    Are You Considering Abaxis (ABAX) Post Solid Q3 Earnings? - Analyst Blog Feb 25 2015
    Medtronic Adds Advanced Uro-Solutions to Neuromodulation - Analyst Blog Feb 24 2015
    ResMed Upped to Hold on Several Growth Initiatives - Analyst Blog Feb 24 2015
    Medtronic's Artificial Pancreas Technology: Key to Diabetes Cure? - Analyst Blog Feb 23 2015
    Zimmer Upbeat on Biomet Takeover, Americas Sales Disappoint - Analyst Blog Feb 23 2015
    Hanger to Amend and Reissue Financial Data; Results Delayed - Analyst Blog Feb 18 2015
    Medtronic Hits 52-Week High on Solid Q3, Portfolio Strength - Analyst Blog Feb 18 2015
    Owens & Minor Lags Q4 Earnings Estimates, Revenues Beat - Analyst Blog Feb 18 2015
    Vascular Solutions Set to Join the S&P SmallCap 600 Feb 17 2015
    Medtronic's Spinal System Wins FDA Nod for Expanded Use - Analyst Blog Feb 17 2015
    Medtronic's Euphora Balloon Catheter Family Expands in UK - Analyst Blog Feb 17 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)